Phil Blog

Phil Blog

Meet Angie Stigliano, Operations Lead Pharmacist at Phil

This week, we had the opportunity to interview Angie Stigliano, Operational Lead Pharmacist, for our Employee Spotlight series. We hope you enjoy getting to know a little bit about her, and her experience at Phil. Tell me a little bit about yourself and what brought you to Phil I have been a pharmacist since 2016

The Role of Scientific Evidence in Specialty Drug Commercialization

Editor’s Note: The role of compelling scientific evidence will continue to be a critical component of the life sciences commercialization playbook to ensure HCP adoption. As the authors of the McGill study explained in this article point out, commercial teams should not underestimate the value of creating a robust, diverse body of scientific evidence when seeking to unlock HCP adoption. However, while clinical efficacy is a necessary condition for prescriber adoption and brand success, it’s no longer sufficient to guarantee it

Why Transparency is Critical in the Patient Access Journey

The Healthcare system is notoriously complicated and opaque, making it arduous for patients to navigate successfully. That’s why there’s been a legislative push to increase transparency across through policies such as the No Surprises Act and Hospital Pricing Transparency rule. Getting access to prescribed therapies to treat complex medical conditions can be especially difficult and stressful for patients

Pharma Injecting Life into Digital Health Amidst Funding Downturn

Editor’s Note: It should come as no surprise that demand in the life sciences industry for health technologies that can accelerate the process of bringing innovative therapies to market and successfully commercializing them is high. However, having been previously burned by technology that failed to deliver on their complex needs in the past, biopharma has lagged behind other industries in its digital transformation. In fact, even today, many commercialization plans still rely on antiquated, telephonic patient engagement strategies and operate with limited visibility into the prescription journey

How Life Science Brands Can Successfully Navigate Retail Challenges

In 2021, 3 out of 4 patients who tried to fill a launch brand were unsuccessful due to payer controls. As life science companies continue to launch innovative specialty-lite therapies, adopting a distribution strategy that ensures patients can access the brand as prescribed – efficiently and affordably – can mean the difference between a successful launch and failing to reach their expected value. As the primary channel for most brands, pharmacy networks play a pivotal role in the distribution, fulfillment, and reimbursement of medications, which means the brand's short- and long-term commercial success ultimately hinges on pharmacy performance

Ready to learn more?

Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.